GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease

This study has been completed.

Study NCT00414622 Information provided by CoMentis

First Received: December 19, 2006 Last Updated: April 18, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2007
Estimated Primary Completion Date:	No date given